Cytospire Therapeutics

News

Cytospire was in the spotlight this morning after announcing an oversubscribed Series A to fund a new form of T-cell engager (TCE) for cancer.

News

Having already committed last year to capital investments of $27 billion in the US to ward off the threat of tariffs, Eli Lilly has upped the ante.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.